WuXi Vaccines Receives Brazil’s ANVISA GMP Certification

2026-02-12 - 05:38

SUZHOU, China, Feb. 12, 2026 /PRNewswire/ — WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced today that it has received Good Manufacturing Practices (GMP) certification for its fill and finish facility (DP17) in Suzhou from Brazil’s Agência Nacional de Vigilância Sanitária (ANVISA). The facility is providing